Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Neurofilament Light Chain as a Biomarker for Global Cognition in Individuals with Mild Vascular Cognitive Impairment
FY 2021-22
Summary
Individuals with vascular conditions are at a greater risk for cognitive impairment (e.g., memory deficits). At its earliest stage, this phenomenon has been termed mild vascular cognitive impairment (mVCI). The cause of mVCI is believed to be related to damage to brain cells, and consequently these individuals can be at a greater risk for progressive cognitive decline. There are currently no treatment options available that can be used to directly treat mVCI. Recently, however, brain stimulation combined with aerobic exercise has emerged as potential treatment intervention for improving individual cognition, as well as reducing damage to brain cells. Thus, this current project has two main objectives. The first will involve measuring the blood concentrations of a biological molecule (i.e., a biomarker) that is known to be associated with increased brain damage. Specifically, the relationship between this biomarker and cognitive impairment in individuals with mVCI will be assessed. The second objective of this research project is to determine whether there is an association between changes in blood levels of this biomarker and cognitive performance after treatment intervention with exercise and brain stimulation. This project will therefore provide valuable insight on the utility of monitoring a brain-damage associated biological marker as a measure for the severity of cognitive impairment in individuals with mVCI. The current research will also evaluate whether this marker can be used to predict responses to treatment intervention in this population of individuals, which may be of important use in future clinical settings.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
466487
Name
Gaur Amish
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Neurofilament Light Chain as a Biomarker for Global Cognition in Individuals with Mild Vascular Cognitive Impairment
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aerobic Exercise; Alzheimer'S Disease; Clinical Research; Dementia; Global Cognition; Mvci; Neurofilament Light Chain; Neuroinflammation; Neuronal Damage; Tdcs
Abstract
Individuals with vascular conditions are at a greater risk for cognitive impairment (e.g., memory deficits). At its earliest stage, this phenomenon has been termed mild vascular cognitive impairment (mVCI). The cause of mVCI is believed to be related to damage to brain cells, and consequently these individuals can be at a greater risk for progressive cognitive decline. There are currently no treatment options available that can be used to directly treat mVCI. Recently, however, brain stimulation combined with aerobic exercise has emerged as potential treatment intervention for improving individual cognition, as well as reducing damage to brain cells. Thus, this current project has two main objectives. The first will involve measuring the blood concentrations of a biological molecule (i.e., a biomarker) that is known to be associated with increased brain damage. Specifically, the relationship between this biomarker and cognitive impairment in individuals with mVCI will be assessed. The second objective of this research project is to determine whether there is an association between changes in blood levels of this biomarker and cognitive performance after treatment intervention with exercise and brain stimulation. This project will therefore provide valuable insight on the utility of monitoring a brain-damage associated biological marker as a measure for the severity of cognitive impairment in individuals with mVCI. The current research will also evaluate whether this marker can be used to predict responses to treatment intervention in this population of individuals, which may be of important use in future clinical settings.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gaur, Amish
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~